혈액검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Blood Testing Market size is expected to reach USD 227.01 Billion in 2034 from USD 110.30 Billion (2025) growing at a CAGR of 8.35% during 2026-2034.

The Global Blood Testing Market is experiencing substantial growth driven by increasing prevalence of chronic diseases and rising awareness about preventive healthcare. Routine blood tests are essential for diagnosing conditions such as diabetes, cardiovascular disorders, and infections. The growing geriatric population and expansion of diagnostic laboratories worldwide are fueling demand for advanced blood testing solutions. Technological innovations in automated analyzers and rapid diagnostic kits are further supporting market expansion.

Major growth drivers include increasing healthcare expenditure, rising demand for early disease detection, and expansion of point-of-care testing services. Government initiatives promoting routine health screenings and improved access to diagnostic services in rural regions are strengthening the market landscape. Moreover, advancements in molecular diagnostics and personalized medicine are expanding the application scope of blood testing. The adoption of home-based testing kits is also contributing to industry growth.

Looking forward, the market is expected to witness strong momentum due to integration of artificial intelligence, digital health platforms, and automation in laboratories. Expansion of telehealth services and decentralized testing models will create new opportunities. Continuous research in biomarker discovery and precision diagnostics will further enhance growth potential. With increasing focus on preventive healthcare, the blood testing market will remain a cornerstone of global medical diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Lipid Panel Testing
• Prostate-Specific Antigen
• Covid-19
• Complete Blood Count (CBC)
• Bun Testing (Blood Urea Nitrogen)
• Glucose Testing
• A1c
• Direct Ldl
• Cortisol
• Creatinine
• Others Tests

By End User

• Hospitals
• Clinics
• Diagnostic Centre
• Research Laboratories
• Others (Blood Banks)

By Method

• Manual
• Automated

COMPANIES PROFILED

• Abbott Diagnostics, BioRad Laboratories Inc, Roche Diagnostics, Quest Diagnostics, Danaher Corporation, Becton Dickinson Company, Biomerica Inc, bioMrieux SA, Siemens Healthcare, Trinity Biotech PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Lipid Panel Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Prostate-Specific Antigen Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Covid-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Complete Blood Count (CBC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Bun Testing (Blood Urea Nitrogen) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Glucose Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. A1c Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Direct Ldl Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Cortisol Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Creatinine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Others Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Centre Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others (Blood Banks) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD TESTING MARKET: BY METHOD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Method
• 6.2. Manual Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Test Type
  • 7.2.2 By End User
  • 7.2.3 By Method
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Test Type
  • 7.3.2 By End User
  • 7.3.3 By Method
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Test Type
  • 7.4.2 By End User
  • 7.4.3 By Method
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Test Type
  • 7.5.2 By End User
  • 7.5.3 By Method
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Test Type
  • 7.6.2 By End User
  • 7.6.3 By Method
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BLOOD TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Diagnostics
  • 9.2.2 Bio-Rad Laboratories Inc
  • 9.2.3 Roche Diagnostics
  • 9.2.4 Quest Diagnostics
  • 9.2.5 Danaher Corporation
  • 9.2.6 Becton Dickinson & Company
  • 9.2.7 Biomerica Inc
  • 9.2.8 BioMAfA(C)Rieux S.A
  • 9.2.9 Siemens Healthcare
  • 9.2.10 Trinity Biotech PLC